Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

1.

Target-based anti-angiogenic therapy in breast cancer.

Wehland M, Bauer J, Infanger M, Grimm D.

Curr Pharm Des. 2012;18(27):4244-57. Review.

PMID:
22632607
[PubMed - indexed for MEDLINE]
2.

Antiangiogenic therapy for metastatic breast cancer: current status and future directions.

Chan A.

Drugs. 2009;69(2):167-81. doi: 10.2165/00003495-200969020-00003. Review.

PMID:
19228074
[PubMed - indexed for MEDLINE]
3.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
4.

New drugs in cancer therapy, National Tumor Institute, Naples, 17-18 June 2004.

Caponigro F, Basile M, de Rosa V, Normanno N.

Anticancer Drugs. 2005 Feb;16(2):211-21.

PMID:
15655420
[PubMed - indexed for MEDLINE]
5.

Evaluation of the current knowledge limitations in breast cancer research: a gap analysis.

Thompson A, Brennan K, Cox A, Gee J, Harcourt D, Harris A, Harvie M, Holen I, Howell A, Nicholson R, Steel M, Streuli C.

Breast Cancer Res. 2008;10(2):R26. doi: 10.1186/bcr1983. Epub 2008 Mar 27. Review.

PMID:
18371194
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Angiogenesis as a target for breast cancer therapy.

Rayson D, Vantyghem SA, Chambers AF.

J Mammary Gland Biol Neoplasia. 1999 Oct;4(4):415-23. Review.

PMID:
10705924
[PubMed - indexed for MEDLINE]
7.

Targeting angiogenesis in advanced breast cancer.

Zelnak AB, O'Regan RM.

BioDrugs. 2007;21(4):209-14. Review.

PMID:
17628118
[PubMed - indexed for MEDLINE]
8.

Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.

Leite de Oliveira R, Hamm A, Mazzone M.

Mol Aspects Med. 2011 Apr;32(2):71-87. doi: 10.1016/j.mam.2011.04.001. Epub 2011 Apr 22. Review.

PMID:
21540050
[PubMed - indexed for MEDLINE]
9.

Implications of the new biology for therapy in breast cancer.

Sledge GW Jr.

Semin Oncol. 1996 Feb;23(1 Suppl 2):76-81. Review.

PMID:
8614850
[PubMed - indexed for MEDLINE]
10.

Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms.

Miletic H, Niclou SP, Johansson M, Bjerkvig R.

Expert Opin Ther Targets. 2009 Apr;13(4):455-68. doi: 10.1517/14728220902806444 . Review.

PMID:
19335067
[PubMed - indexed for MEDLINE]
11.

Novel strategies towards the use of anti-angiogenic agents in breast cancer.

Bakker JL, Meijers-Heijboer H, Verheul H.

Eur J Pharmacol. 2013 Oct 5;717(1-3):36-9. doi: 10.1016/j.ejphar.2013.03.035. Epub 2013 Mar 30. Review.

PMID:
23545363
[PubMed - indexed for MEDLINE]
12.

Anti-angiogenic therapy in breast cancer.

Atiqur Rahman M, Toi M.

Biomed Pharmacother. 2003 Dec;57(10):463-70. Review.

PMID:
14637390
[PubMed - indexed for MEDLINE]
13.

Antiangiogenic therapies in breast cancer.

Sarmiento R, D'Andrea MR, Cacciamani F, Salerno F, Gasparini G.

Curr Opin Investig Drugs. 2009 Dec;10(12):1334-45. Review.

PMID:
19943205
[PubMed - indexed for MEDLINE]
14.

Dual function of RGD-modified VEGI-192 for breast cancer treatment.

Wu J, Jiang Y, Yang W, He Z, Meng S, Zhang Q, Lin M, Zhang H, Li W, Yang Y, Jia Y, Qian L, Lu D, Cai W, Luo G, Wang Y, Zhu X, Li M.

Bioconjug Chem. 2012 Apr 18;23(4):796-804. doi: 10.1021/bc2006576. Epub 2012 Mar 29.

PMID:
22455451
[PubMed - indexed for MEDLINE]
15.

Antiangiogenic therapy in malignant glioma: promise and challenge.

Sathornsumetee S, Rich JN.

Curr Pharm Des. 2007;13(35):3545-58. Review.

PMID:
18220791
[PubMed - indexed for MEDLINE]
16.

Progression and treatment of HER2-positive breast cancer.

Davoli A, Hocevar BA, Brown TL.

Cancer Chemother Pharmacol. 2010 Mar;65(4):611-23. doi: 10.1007/s00280-009-1208-1. Epub 2009 Dec 20.

PMID:
20087739
[PubMed - indexed for MEDLINE]
17.

Antiangiogenic strategies, compounds, and early clinical results in breast cancer.

Morabito A, Sarmiento R, Bonginelli P, Gasparini G.

Crit Rev Oncol Hematol. 2004 Feb;49(2):91-107. Review.

PMID:
15012971
[PubMed - indexed for MEDLINE]
18.

Controlling angiogenesis in breast cancer: a systematic review of anti-angiogenic trials.

Mackey JR, Kerbel RS, Gelmon KA, McLeod DM, Chia SK, Rayson D, Verma S, Collins LL, Paterson AH, Robidoux A, Pritchard KI.

Cancer Treat Rev. 2012 Oct;38(6):673-88. doi: 10.1016/j.ctrv.2011.12.002. Epub 2012 Feb 23. Review.

PMID:
22365657
[PubMed - indexed for MEDLINE]
19.

Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool.

Gasparini G, Harris AL.

J Clin Oncol. 1995 Mar;13(3):765-82. Review.

PMID:
7533829
[PubMed - indexed for MEDLINE]
20.

Biological therapy of breast cancer: recent clinical applications.

Baar J.

Curr Opin Investig Drugs. 2007 Dec;8(12):987-95.

PMID:
18058569
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk